USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Cellresearch Corporation PTE. Ltd.

USPTO PatentsView assignee record - 14 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cellresearch ranks #19,585 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 8 technology areas.

#19,585
of 49,997 US assignees by volume
27th percentile
by Innovation Score (28.2/100)
8.1
avg claims per patent
-14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19585 · Foreign Corporation #19,585 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,585/49,997
  • PHOTO-FINISH Celagenex Research…
  • CPC-NARROW C12N · 8 areas
  • INNOV-THIN 28.2/100
  • CLAIMS-PAR 8.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DOWN -14% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Celagenex Research (INDIA) PVT. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cellresearch’s 28.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cellresearch

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cellresearch's Innovation Score is 28.2/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cellresearch?

Each dot is one of Cellresearch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cellresearch’s own 8.1 claims/patent is at or below the 10.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Cellresearch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 051015202530 Granted patents (volume) Avg claims / patent Celagenex Research (INDIA) PVT. Ltd. - 14, 7.93Celagenex Researc…Celerint, LLC - 14, 16.43CelerintCellcentric GMBH & Co. KG - 14, 10.07Cellcentric & KGCellivery Therapeutics, Inc. - 14, 12.36Cellivery Therape…Cempra Pharmaceuticals, Inc. - 14, 24.79Cempra Pharmaceut…Certis Cisco Security PTE Ltd - 14, 21.43Certis Cisco Secu…Certoplast Technische Klebebaender GMBH - 14, 9.07Certoplast Techni…Checkmate Lifting & Safety Ltd - 14, 5.5Checkmate Lifting…Cellresearch Corporation PTE. Ltd. - 14, 8.14Cellresearch PTE
Cellresearch vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cellresearch's grants concentrate

Cellresearch Corporation PTE. Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Cellresearch sits between Celagenex Research (INDIA) PVT. Ltd. and Checkmate Lifting & Safety Ltd.

Cellresearch's three-year grant acceleration

Cellresearch Corporation PTE. Ltd. shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Cellresearch's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cellresearch holds 14 patents at rank #19,570, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cellresearch

By rank, the assignees closest to #19,570 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Cellresearch's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cellresearch, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Cellresearch ranks #748 of 4,144 assignees by patent count in that subclass.

Cellresearch's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2015201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cellresearch Corporation PTE. Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 14.3%
2017 2 14.3%
2018 1 7.1%
2019 2 14.3%
2020 1 7.1%
2021 2 14.3%
2022 1 7.1%
2023 1 7.1%
2024 1 7.1%
2025partial year 1 7.1%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Cellresearch Corporation PTE. Ltd.'s patent record in context - here's where to go next.

  • Cellresearch Corporation PTE. Ltd.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #19,585 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Cellresearch Corporation PTE. Ltd. against Celagenex Research (INDIA) PVT. Ltd., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.